AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 256: F875-F881, 1989;
0363-6127/89 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caramelo, C.
Right arrow Articles by Schrier, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caramelo, C.
Right arrow Articles by Schrier, R. W.

AJP - Renal Physiology, Vol 256, Issue 5 875-F881, Copyright © 1989 by American Physiological Society

ARTICLES

Phorbol esters and arginine vasopressin in vascular smooth muscle cell activation

C. Caramelo, K. Okada, P. Tsai and R. W. Schrier
Department of Medicine, University of Colorado School of Medicine, Denver 80262.

Vascular smooth muscle cell (VSMC) contraction is the result of several interacting mechanisms. In this study such interactions in rat aortic VSMC in culture were examined with a focus on the role of protein kinase C-mediated mechanisms. The change in shape of VSMC was used as a functional parameter representative of contraction. The protein kinase C agonist, phorbol myristate acetate (PMA), and arginine vasopressin (AVP) induced a dose-dependent, progressive change in VSMC shape. The effects of PMA differed from AVP in the delay time necessary to reach the plateau of the response and in the absence with PMA of a transient rise in cytosolic free Ca2+ [( Ca2+]i). The effect of PMA was potentiated by the Ca2+ ionophore, ionomycin, and involved a verapamil-inhibitable transmembrane Ca2+ transport system. Protein kinase C inhibition by either isoquinolin-sulfonyl-O-2-methylpiperazine or protein kinase C desensitization significantly reduced the cell shape change induced by either PMA or AVP. In the case of AVP, this inhibitory effect occurred without affecting the [Ca2+]i transient. Therefore, the [Ca2+]i transient appears to be independent of acute protein kinase C regulation, since it is apparently not affected by the absence of protein kinase C activity. Protein kinase C activation by PMA produced intracellular alkalinization that is blocked by the sodium transport antagonist, amiloride. Amiloride also blocked the cell shape change induced by PMA or AVP. The intracellular alkalinization, however, was not necessary for the cell shape change to occur. Specifically, with the use of VSMC preincubated with fetal calf serum, PMA did not induce cellular pH changes but still produced cell shape changes.


This article has been cited by other articles:


Home page
 HypertensionHome page
T. Ito, O. Kozawa, K. Tanabe, M. Niwa, H. Matsuno, N. Sakai, H. Ito, K. Kato, and T. Uematsu
p38 MAP Kinase Is Required for Vasopressin-Stimulated HSP27 Induction in Aortic Smooth Muscle Cells
Hypertension, February 1, 2000; 35(2): 673 - 678.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. Bauer, C. Dau, A. Cavarape, F. Schaefer, H. Ehmke, and N. Parekh
ANG II- and TxA2-induced mesenteric vasoconstriction in rats is mediated by separate cell signaling pathways
Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H1 - H7.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S.-M. Yu, S.-Y. Tsai, J.-H. Guh, F.-N. Ko, C.-M. Teng, and J. T. Ou
Mechanism of Catecholamine-Induced Proliferation of Vascular Smooth Muscle Cells
Circulation, August 1, 1996; 94(3): 547 - 554.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online